In accordance with these findings, previous study showed that simvastatin and farnesyltransferase inhibitor decrease apoptosis (inhibits caspase-3, Bax and Bim expression) of hepatocytes and spleen lymphocytes in endotoxemia (Shinozaki et al., 2010). Here, CASP3 is linked to serum lipopolysaccharide activity.